Denosumab Injection Combined with Intramedullary Nail Fixation for Osteoporotic Fractures.

IF 1.3 4区 医学 Q3 ORTHOPEDICS
Indian Journal of Orthopaedics Pub Date : 2026-03-17 eCollection Date: 2026-09-01 DOI:10.1007/s43465-026-01770-w
Weichu Cai, Changfan Li, Shuoxin Chen, Yijia Gao
{"title":"Denosumab Injection Combined with Intramedullary Nail Fixation for Osteoporotic Fractures.","authors":"Weichu Cai, Changfan Li, Shuoxin Chen, Yijia Gao","doi":"10.1007/s43465-026-01770-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical efficacy of denosumab injection combined with intramedullary nail fixation for osteoporotic femoral intertrochanteric fractures.</p><p><strong>Methods: </strong>A total of 106 patients diagnosed with osteoporotic femoral intertrochanteric fractures, classified according to the Evans-Jensen system, who were admitted to The First Affiliated Hospital of Guangzhou University of Chinese Medicine between May 2019 and May 2024. All patients underwent internal fixation using the proximal femoral nail antirotation (PFNA) system. The study group received denosumab injections within 1 week postoperatively, and both groups were administered conventional osteoporosis treatment following surgery. The baseline data (age, sex, cause of injury, and Evans-Jensen classification), operation time, intraoperative blood loss, length of hospital stay, fracture healing time, <i>T</i> value of hip bone density, and postoperative complications were compared between these two groups. The VAS score and HHS was evaluated 1 year after surgery.</p><p><strong>Results: </strong>All 106 patients were followed up for at least 1 year. There was no significant difference in operation time, intraoperative blood loss, hospital stays, fracture healing time, and HHS between the two groups (<i>P</i> > 0.05). The incidence of postoperative complications, <i>T</i> value of hip bone density, and VAS score in the study group was significantly lower than that in the control group, and the difference between the groups was statistically significant (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>In summary, the integrative therapeutic protocol combining denosumab administration with proximal femoral nail antirotation (PFNA) fixation demonstrates marked efficacy in enhancing femoral neck bone mineral density and reducing fracture-related limb pain among elderly patients with osteoporotic intertrochanteric fractures. This evidence-based dual-intervention strategy not only optimizes fracture healing outcomes, but also represents a valuable clinical approach for comprehensive postoperative rehabilitation in this vulnerable patient population.</p>","PeriodicalId":13338,"journal":{"name":"Indian Journal of Orthopaedics","volume":"60 9","pages":"2582-2587"},"PeriodicalIF":1.3000,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13627542/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Orthopaedics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s43465-026-01770-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate the clinical efficacy of denosumab injection combined with intramedullary nail fixation for osteoporotic femoral intertrochanteric fractures.

Methods: A total of 106 patients diagnosed with osteoporotic femoral intertrochanteric fractures, classified according to the Evans-Jensen system, who were admitted to The First Affiliated Hospital of Guangzhou University of Chinese Medicine between May 2019 and May 2024. All patients underwent internal fixation using the proximal femoral nail antirotation (PFNA) system. The study group received denosumab injections within 1 week postoperatively, and both groups were administered conventional osteoporosis treatment following surgery. The baseline data (age, sex, cause of injury, and Evans-Jensen classification), operation time, intraoperative blood loss, length of hospital stay, fracture healing time, T value of hip bone density, and postoperative complications were compared between these two groups. The VAS score and HHS was evaluated 1 year after surgery.

Results: All 106 patients were followed up for at least 1 year. There was no significant difference in operation time, intraoperative blood loss, hospital stays, fracture healing time, and HHS between the two groups (P > 0.05). The incidence of postoperative complications, T value of hip bone density, and VAS score in the study group was significantly lower than that in the control group, and the difference between the groups was statistically significant (P < 0.05).

Conclusion: In summary, the integrative therapeutic protocol combining denosumab administration with proximal femoral nail antirotation (PFNA) fixation demonstrates marked efficacy in enhancing femoral neck bone mineral density and reducing fracture-related limb pain among elderly patients with osteoporotic intertrochanteric fractures. This evidence-based dual-intervention strategy not only optimizes fracture healing outcomes, but also represents a valuable clinical approach for comprehensive postoperative rehabilitation in this vulnerable patient population.

地诺单抗联合髓内钉固定治疗骨质疏松性骨折。
目的:探讨地沙单抗注射液联合髓内钉固定治疗骨质疏松性股骨粗隆间骨折的临床疗效。方法:选取2019年5月至2024年5月广州中医药大学第一附属医院收治的106例骨质疏松性股骨粗隆间骨折患者,按Evans-Jensen分级。所有患者均采用股骨近端钉防旋转(PFNA)系统进行内固定。研究组术后1周内给予地诺单抗注射,两组术后均给予常规骨质疏松治疗。比较两组患者的基线资料(年龄、性别、损伤原因、Evans-Jensen分型)、手术时间、术中出血量、住院时间、骨折愈合时间、髋部骨密度T值、术后并发症。术后1年评估VAS评分和HHS。结果:106例患者均随访1年以上。两组患者手术时间、术中出血量、住院时间、骨折愈合时间、HHS比较,差异均无统计学意义(P < 0.05)。研究组术后并发症发生率、髋部骨密度T值、VAS评分均显著低于对照组,组间差异有统计学意义(P)。综上所述,denosumab联合股骨近端钉防旋转(PFNA)固定的综合治疗方案在提高老年骨质疏松性转子间骨折患者股骨颈骨密度和减轻骨折相关肢体疼痛方面疗效显著。这种以证据为基础的双干预策略不仅优化了骨折愈合结果,而且为这一弱势患者群体的全面术后康复提供了一种有价值的临床方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
185
审稿时长
9 months
期刊介绍: IJO welcomes articles that contribute to Orthopaedic knowledge from India and overseas. We publish articles dealing with clinical orthopaedics and basic research in orthopaedic surgery. Articles are accepted only for exclusive publication in the Indian Journal of Orthopaedics. Previously published articles, articles which are in peer-reviewed electronic publications in other journals, are not accepted by the Journal. Published articles and illustrations become the property of the Journal. The copyright remains with the journal. Studies must be carried out in accordance with World Medical Association Declaration of Helsinki.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书